CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer Patients (CANUT-QVA)

Cancer patients are at high risk of undernutrition, which is generally more pronounced for solid tumours (upper digestive tract, Ear Nose and Throat (ENT), bronchial tubes). This undernutrition leads to major weight loss and cachexia, and may represent the first sign of a call for a diagnosis of cancer. Cancer-related undernutrition is multi-factorial origins and has multiple consequences.

Chemotherapy treatments can induce various adverse effects in patients, including sensory disturbances at the beginning of treatment in addition to disturbances that may already be present before any treatment. The alteration of taste and odour, observed in 86% of patients, can induce a change in food preferences, promote the development of aversions, and therefore, lead to a significant reduction in the pleasure of eating. Loss of appetite, decreased food intake and the development of aversions to certain foods are situations experienced by a large proportion of patients treated with chemotherapy.

The assessment of taste disorders in patients treated with chemotherapy is established through the use of questionnaires, interviews and taste tests.

Changes in the perception and identification of salty, sweet, bitter and sour flavours are common in patients treated with chemotherapy.

As regards food products, patients report developing olfactory hypersensitivity mainly for food of animal origin, in particular for odours of fish, frying, cheese and eggs.

The CANUT project aims to study the effect of pathology and chemotherapy on gustatory and olfactory mechanisms, and in particular on interindividual differences in the perception and appreciation of food.

In order to monitor the evolution of patients' eating habits over time, the diet-related quality of life questionnaire (CANUT-QVA) was constructed from items selected from the Well-being related to Food questionnaire (WELLBFQ) after eliminating questions that were too general or expressed in terms of importance to use perception-related responses as a priority.

After this part, an evaluation of the 9 dimensions of the CANUT-QVA questionnaire will be performed.

Study Overview

• Status: Completed
• Conditions: Chemotherapy Effect; Taste Disorders; Olfactory Disorder; Undernutrition; Hematologic Cancer; Chemotherapy-Induced Change
• Intervention / Treatment: Other: Evaluation of the 9 dimensions of the CANUT-QVA questionnaire

• Study Type: Observational
• Enrollment (Actual): 127

Contacts and Locations

Study Locations

• France
  • Pierre-Bénite, France, 69310
    • Hospices Civils de Lyon, Groupement Hospitalier Lyon Sud, Service pneumologie

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 14 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Patients with solid or hematological cancer complete the CANUT-QVA questionnaire.

Description

Inclusion Criteria:

• Patient with solid or hematological cancer (any stage of disease and any treatment) diagnosed within 12 months of inclusion.
• Patient who does not object to participate in the trial
• Patient affiliated to a social security system

Exclusion Criteria:

• Minor patient (age <18 years).
• Patient under trusteeship, curatorship or protective measures.
• Patient who has already completed the questionnaire.
• Patient not sufficiently able to speak French to answer the questionnaire

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort

Intervention / Treatment

Patients with solid or hematological cancer; All the patients complete the CANUT-QVA questionnaire

Other: Evaluation of the 9 dimensions of the CANUT-QVA questionnaire; Evaluation of the contribution of a new questionnaire by patients with solid or hematological cancer according to 9 dimensions: Making food; Place where the meals are eaten; Eating and drinking: Nutrition; Eating and drinking: The pleasure of tasting, chewing; Eating and drinking: Satiated, well being; Food preparation: Supply, choice, presentation; Eating and drinking: Feelings; After eating: heaviness, discomfort, hunger; Taste/Odour Problems to confirm the number and structure of factors obtained at the end of the pre-study and to remove redundant questions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Validate the 9 dimensions of the CANUT-QVA questionnaire identified during the general population analysis.	The main evaluation criterion will be the adequacy between the responses to the food quality of life questionnaire by patients and the structure of the 9 dimensions as presented in the context (relevance of the questions for each dimension).	day 0

Collaborators and Investigators

• Sponsor: Hospices Civils de Lyon

Study record dates

Study Major Dates

• Study Start (Actual): January 9, 2020
• Primary Completion (Actual): March 12, 2020
• Study Completion (Actual): March 12, 2020

Study Registration Dates

• First Submitted: January 16, 2020
• First Submitted That Met QC Criteria: January 17, 2020
• First Posted (Actual): January 21, 2020

Study Record Updates

• Last Update Posted (Actual): July 9, 2021
• Last Update Submitted That Met QC Criteria: July 6, 2021
• Last Verified: July 1, 2021

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Nervous System Diseases; Neoplasms; Neoplasms by Site; Neurologic Manifestations; Hematologic Diseases; Nutrition Disorders; Sensation Disorders; Hematologic Neoplasms; Disease; Malnutrition; Taste Disorders
• Other Study ID Numbers: 69HCL19_0617

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No